NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation. Why Is Ardent being Investigated for Securities Violations? Ardent is a provider of healthcare in mid-sized urban communitie ...

Core Insights - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company also increased its professional liability reserves by $54 million due to adverse developments from claims between 2019 and 2022, as well as broader industry trends [3]. Stock Market Reaction - Following the financial disclosures on November 12, 2025, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3].

Core Insights - Hagens Berman has initiated an investigation into Ardent Health, Inc. for potential securities law violations following significant adverse accounting adjustments totaling $97 million, which resulted in a stock decline of over 33% [1][2]. Financial Disclosures - The investigation centers on whether Ardent's management was aware of material weaknesses in internal controls related to revenue recognition and liability reserves, particularly given the $43 million revenue reduction and $54 million increase in reserves [2][3]. - The adverse disclosures on November 12, 2025, regarding the $97 million adjustment and the significant reduction in 2025 adjusted EBITDA guidance indicate a divergence from previously reported financial health [4]. Legal Focus Areas - Key legal focus areas include the adequacy of controls regarding the $43 million revenue reduction and the $54 million increase in liability reserves, as well as the timing of disclosures related to persistent payor denials [4]. - The investigation will also assess whether the adverse prior period claim developments were timely and properly reserved under GAAP and SEC guidelines [4]. Investor Impact - Hagens Berman is advising investors who purchased ARDT shares and suffered losses due to the undisclosed revenue and reserve issues, emphasizing the firm's track record of securing over $325 billion in settlements for investors [5].

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into Ardent Health, Inc. for possible securities fraud following significant financial disclosures that negatively impacted the company's stock price [1][3]. Financial Disclosures - On November 12, 2025, Ardent reported a $43 million reduction in revenue due to changes in accounting estimates regarding the collectability of accounts receivable [3]. - The company also disclosed a $54 million increase in its professional liability reserves related to claims in New Mexico [3]. - Following these disclosures, Ardent's stock price experienced a significant decline during pre-market trading on November 13, 2025 [3]. Legal Actions - Investors are encouraged to contact the Portnoy Law Firm to discuss their legal rights and potential claims for recovering losses [2]. - The firm has a history of recovering over $5.5 billion for investors affected by corporate wrongdoing [4].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws following a significant drop in its stock price, which fell over 33% after the company reported disappointing Q3 2025 financial results [1][3][4]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue due to "hindsight evaluations of historical collection trends" [4]. - The company also increased its professional liability reserves by $54 million, citing "adverse prior period claim developments" from claims between 2019 and 2022, as well as broader industry trends [4]. Investigation Details - The investigation focuses on Ardent's accounting practices, particularly regarding accounts receivable and professional liability reserves [3]. - Bleichmar Fonti & Auld LLP, a leading securities law firm, is conducting the investigation and has urged investors to come forward [1][5].

Core Insights - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company also increased its professional liability reserves by $54 million due to adverse developments from claims made between 2019 and 2022, as well as broader industry trends [3]. - Following the financial disclosures, Ardent's stock price dropped over 33% on November 13, 2025 [3]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages affected investors to seek additional information regarding potential legal options [1][4].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. - Following these disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages affected investors to seek additional information and potential legal options [2][5]. - The law firm operates on a contingency fee basis, meaning shareholders are not responsible for court costs or litigation expenses [5]. Company Overview - Ardent Health, Inc. provides healthcare services in mid-sized urban communities across the U.S., operating a network of hospitals, ambulatory facilities, and physician practices [3].

Core Insights - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company also increased its professional liability reserves by $54 million due to adverse developments from claims made between 2019 and 2022, as well as broader industry trends [3]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages affected investors to seek additional information regarding potential legal options [1][4]. - The law firm operates on a contingency fee basis, meaning shareholders are not responsible for court costs or litigation expenses [4]. Company Overview - Ardent Health operates a network of hospitals, ambulatory facilities, and physician practices primarily in mid-sized urban communities across the U.S. [2].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [2][3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. Stock Market Reaction - Following the financial report, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4]. Legal Implications - Investors in Ardent Health are encouraged to seek legal options due to the ongoing investigation and potential losses incurred [5][7]. Law Firm Background - Bleichmar Fonti & Auld LLP is a leading law firm specializing in securities class actions and has a strong track record, including recovering over $900 million from Tesla's Board of Directors [6].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting "hindsight evaluations of historical collection trends" [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. Stock Market Reaction - Following the financial report, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4].